Literature DB >> 23051580

Haem oxygenase-1 inhibits phosphorylation of the Helicobacter pylori oncoprotein CagA in gastric epithelial cells.

Alain P Gobert1, Thomas Verriere, Thibaut de Sablet, Richard M Peek, Rupesh Chaturvedi, Keith T Wilson.   

Abstract

The cytotoxin-associated gene A protein (CagA) plays a pivotal role in the aetiology of Helicobacter pylori-associated gastric diseases. CagA is injected into the cytoplasm of host cells by a type IV secretion system, and is phosphorylated on tyrosine residues by the host enzyme c-Src. We previously reported that the enzyme haem oxygenase-1 (HO-1) inhibits IL-8 secretion by H. pylori-infected cells. However, the cellular mechanism by which HO-1 regulates the innate immune function of infected cells remains unknown. We now show that nitric oxide and haemin, two inducers of HO-1, decrease the level of phosphorylated CagA (p-CagA) in H. pylori-infected gastric epithelial cells and this is blocked by either pharmacological inhibition of HO-1 or siRNA knockdown of hmox-1. Moreover, forced expression of HO-1 by transfection of a plasmid expressing hmox-1 also results in a strong attenuation of CagA phosphorylation. This occurs through the inhibition of H. pylori-induced c-Src phosphorylation/activation by HO-1. Consequently, H. pylori-induced cytoskeletal rearrangements and activation of the pro-inflammatory response mediated by p-CagA are inhibited in HO-1-expressing cells. These data highlight a mechanism by which the innate immune response of the host can restrict the pathogenicity of H. pylori by attenuating CagA phosphorylation in gastric epithelial cells.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23051580      PMCID: PMC3524338          DOI: 10.1111/cmi.12039

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  56 in total

1.  SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein.

Authors:  Hideaki Higashi; Ryouhei Tsutsumi; Syuichi Muto; Toshiro Sugiyama; Takeshi Azuma; Masahiro Asaka; Masanori Hatakeyama
Journal:  Science       Date:  2001-12-13       Impact factor: 47.728

2.  Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk.

Authors:  Thibaut de Sablet; M Blanca Piazuelo; Carrie L Shaffer; Barbara G Schneider; Mohammad Asim; Rupesh Chaturvedi; Luis E Bravo; Liviu A Sicinschi; Alberto G Delgado; Robertino M Mera; Dawn A Israel; Judith Romero-Gallo; Richard M Peek; Timothy L Cover; Pelayo Correa; Keith T Wilson
Journal:  Gut       Date:  2011-02-25       Impact factor: 23.059

3.  Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival.

Authors:  A P Gobert; D J McGee; M Akhtar; G L Mendz; J C Newton; Y Cheng; H L Mobley; K T Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells.

Authors:  S Backert; S Moese; M Selbach; V Brinkmann; T F Meyer
Journal:  Mol Microbiol       Date:  2001-11       Impact factor: 3.501

5.  Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia.

Authors:  Isabelle C Arnold; Josephine Y Lee; Manuel R Amieva; Axel Roers; Richard A Flavell; Tim Sparwasser; Anne Müller
Journal:  Gastroenterology       Date:  2010-06-22       Impact factor: 22.682

6.  Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism.

Authors:  Cody C Allison; Thomas A Kufer; Elisabeth Kremmer; Maria Kaparakis; Richard L Ferrero
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 7.  Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature.

Authors:  Jay Luther; Maneesh Dave; Peter D R Higgins; John Y Kao
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

8.  CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions.

Authors:  L A Sicinschi; P Correa; R M Peek; M C Camargo; M B Piazuelo; J Romero-Gallo; S S Hobbs; U Krishna; A Delgado; R Mera; L E Bravo; B G Schneider
Journal:  Clin Microbiol Infect       Date:  2009-05-15       Impact factor: 8.067

9.  Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination.

Authors:  Acacia Lamb; Xiao-Dong Yang; Ying-Hung N Tsang; Jiang-Dong Li; Hideaki Higashi; Masanori Hatakeyama; Richard M Peek; Steven R Blanke; Lin-Feng Chen
Journal:  EMBO Rep       Date:  2009-10-09       Impact factor: 8.807

Review 10.  Coadaptation of Helicobacter pylori and humans: ancient history, modern implications.

Authors:  John C Atherton; Martin J Blaser
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

View more
  13 in total

Review 1.  At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.

Authors:  Dana M Hardbower; Richard M Peek; Keith T Wilson
Journal:  J Leukoc Biol       Date:  2014-05-27       Impact factor: 4.962

2.  Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.

Authors:  Johanna C Sierra; Mohammad Asim; Thomas G Verriere; M Blanca Piazuelo; Giovanni Suarez; Judith Romero-Gallo; Alberto G Delgado; Lydia E Wroblewski; Daniel P Barry; Richard M Peek; Alain P Gobert; Keith T Wilson
Journal:  Gut       Date:  2017-05-04       Impact factor: 23.059

Review 3.  Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

4.  Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori.

Authors:  Alain P Gobert; Thomas Verriere; Mohammad Asim; Daniel P Barry; M Blanca Piazuelo; Thibaut de Sablet; Alberto G Delgado; Luis E Bravo; Pelayo Correa; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson
Journal:  J Immunol       Date:  2014-08-08       Impact factor: 5.422

Review 5.  Chronic inflammation and oxidative stress: the smoking gun for Helicobacter pylori-induced gastric cancer?

Authors:  Dana M Hardbower; Thibaut de Sablet; Rupesh Chaturvedi; Keith T Wilson
Journal:  Gut Microbes       Date:  2013-06-28

Review 6.  Polyamine- and NADPH-dependent generation of ROS during Helicobacter pylori infection: A blessing in disguise.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Free Radic Biol Med       Date:  2016-09-25       Impact factor: 7.376

7.  The CO donor CORM-2 inhibits LPS-induced vascular cell adhesion molecule-1 expression and leukocyte adhesion in human rheumatoid synovial fibroblasts.

Authors:  Pei-Ling Chi; Yu-Chen Chuang; Yu-Wen Chen; Chih-Chung Lin; Li-Der Hsiao; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 8.  Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.

Authors:  Aleksandra Sokic-Milutinovic; Tamara Alempijevic; Tomica Milosavljevic
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

9.  Presence of terminal EPIYA phosphorylation motifs in Helicobacter pylori CagA contributes to IL-8 secretion, irrespective of the number of repeats.

Authors:  Konstantinos S Papadakos; Ioanna S Sougleri; Andreas F Mentis; Efstathios Hatziloukas; Dionyssios N Sgouras
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  Crude Preparations of Helicobacter pylori Outer Membrane Vesicles Induce Upregulation of Heme Oxygenase-1 via Activating Akt-Nrf2 and mTOR-IκB Kinase-NF-κB Pathways in Dendritic Cells.

Authors:  Su Hyuk Ko; Da Jeong Rho; Jong Ik Jeon; Young-Jeon Kim; Hyun Ae Woo; Nayoung Kim; Jung Mogg Kim
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.